Skip to main content
PMC home page
Journal of Epidemiology and Community Health logoLink to Journal of Epidemiology and Community Health
. 1999 Jul;53(7):393–398. doi: 10.1136/jech.53.7.393

Risk of dementia in parents of probands with and without the apolipoprotein E4 allele. The EVA study

S Danet, T Brousseau, F Richard, P Amouyel, C Berr
PMCID: PMC1756916  PMID: 10492731

Abstract

STUDY OBJECTIVE: Age, family history of dementia and the epsilon 4 allele of the apolipoprotein E gene have been associated with Alzheimer's disease (AD). Considering the strength of APOE-epsilon 4 as a genetic risk factor for AD, this factor might explain a large part of the association between AD and a family history of dementia. Therefore, in the general population, a higher frequency of dementia should be observed among parents of probands with at least one epsilon 4 allele than in parents of probands without this allele. DESIGN, SETTING, AND PARTICIPANTS: The study investigated a sample of 1153 volunteers between 59 and 71 years old, genotyped for the APOE gene, all participating in the EVA study. Dementia in their parents was determined using a self reported questionnaire. MAIN RESULTS: The frequency of dementia in 2164 parents was examined and it was found that 245 were demented. The percentage of demented parents was 13.0% in the subgroup of parents of subjects having one or two epsilon 4 alleles and 10.8% in the other subgroup. The relative risk of dementia among parents according to the APOE-epsilon 4 status of probands, was calculated using a Cox model adjusted for the educational level of parents and their history of stroke: RR = 1.21 (95% CI 0.90, 1.63). CONCLUSION: This lack of association supports the observation that in the general population, APOE-epsilon 4 cannot explain a large part of family history of dementia.

 

Full Text

The Full Text of this article is available as a PDF (119.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amouyel P., Vidal O., Launay J. M., Laplanche J. L. The apolipoprotein E alleles as major susceptibility factors for Creutzfeldt-Jakob disease. The French Research Group on Epidemiology of Human Spongiform Encephalopathies. Lancet. 1994 Nov 12;344(8933):1315–1318. doi: 10.1016/s0140-6736(94)90691-2. [DOI] [PubMed] [Google Scholar]
  2. Berr C., Dufouil C., Brousseau T., Richard F., Amouyel P., Marceteau E., Alpérovitch A. Early effect of ApoE-epsilon 4 allele on cognitive results in a group of highly performing subjects: the EVA study. Etude sur le Vieillissement Artériel. Neurosci Lett. 1996 Oct 25;218(1):9–12. doi: 10.1016/0304-3940(96)13059-7. [DOI] [PubMed] [Google Scholar]
  3. Bonaiuto S., Rocca W. A., Lippi A., Giannandrea E., Mele M., Cavarzeran F., Amaducci L. Education and occupation as risk factors for dementia: a population-based case-control study. Neuroepidemiology. 1995;14(3):101–109. doi: 10.1159/000109785. [DOI] [PubMed] [Google Scholar]
  4. Brousseau T., Legrain S., Berr C., Gourlet V., Vidal O., Amouyel P. Confirmation of the epsilon 4 allele of the apolipoprotein E gene as a risk factor for late-onset Alzheimer's disease. Neurology. 1994 Feb;44(2):342–344. doi: 10.1212/wnl.44.2.342. [DOI] [PubMed] [Google Scholar]
  5. Bétard C., Robitaille Y., Gee M., Tiberghien D., Larrivée D., Roy P., Mortimer J. A., Gauvreau D. Apo E allele frequencies in Alzheimer's disease, Lewy body dementia, Alzheimer's disease with cerebrovascular disease and vascular dementia. Neuroreport. 1994 Oct 3;5(15):1893–1896. doi: 10.1097/00001756-199410000-00013. [DOI] [PubMed] [Google Scholar]
  6. Chartier-Harlin M. C., Parfitt M., Legrain S., Pérez-Tur J., Brousseau T., Evans A., Berr C., Vidal O., Roques P., Gourlet V. Apolipoprotein E, epsilon 4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer's disease: analysis of the 19q13.2 chromosomal region. Hum Mol Genet. 1994 Apr;3(4):569–574. doi: 10.1093/hmg/3.4.569. [DOI] [PubMed] [Google Scholar]
  7. Duara R., Barker W. W., Lopez-Alberola R., Loewenstein D. A., Grau L. B., Gilchrist D., Sevush S., St George-Hyslop S. Alzheimer's disease: interaction of apolipoprotein E genotype, family history of dementia, gender, education, ethnicity, and age of onset. Neurology. 1996 Jun;46(6):1575–1579. doi: 10.1212/wnl.46.6.1575. [DOI] [PubMed] [Google Scholar]
  8. Frisoni G. B., Bianchetti A., Govoni S., Trabucchi M., Calabresi L., Franceschini G. Association of apolipoprotein E E4 with vascular dementia. JAMA. 1994 May 4;271(17):1317–1317. [PubMed] [Google Scholar]
  9. Hardy J., Crook R., Prihar G., Roberts G., Raghavan R., Perry R. Senile dementia of the Lewy body type has an apolipoprotein E epsilon 4 allele frequency intermediate between controls and Alzheimer's disease. Neurosci Lett. 1994 Nov 21;182(1):1–2. doi: 10.1016/0304-3940(94)90190-2. [DOI] [PubMed] [Google Scholar]
  10. Heun R., Hardt J., Burkart M., Maier W. Validity of the family history method in relatives of gerontopsychiatric patients. Psychiatry Res. 1996 Jun 1;62(3):227–238. doi: 10.1016/0165-1781(96)02891-0. [DOI] [PubMed] [Google Scholar]
  11. Hixson J. E., Vernier D. T. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res. 1990 Mar;31(3):545–548. [PubMed] [Google Scholar]
  12. Hofman A., Ott A., Breteler M. M., Bots M. L., Slooter A. J., van Harskamp F., van Duijn C. N., Van Broeckhoven C., Grobbee D. E. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study. Lancet. 1997 Jan 18;349(9046):151–154. doi: 10.1016/S0140-6736(96)09328-2. [DOI] [PubMed] [Google Scholar]
  13. Hofman A., Rocca W. A., Brayne C., Breteler M. M., Clarke M., Cooper B., Copeland J. R., Dartigues J. F., da Silva Droux A., Hagnell O. The prevalence of dementia in Europe: a collaborative study of 1980-1990 findings. Eurodem Prevalence Research Group. Int J Epidemiol. 1991 Sep;20(3):736–748. doi: 10.1093/ije/20.3.736. [DOI] [PubMed] [Google Scholar]
  14. Koller W. C., Glatt S. L., Hubble J. P., Paolo A., Tröster A. I., Handler M. S., Horvat R. T., Martin C., Schmidt K., Karst A. Apolipoprotein E genotypes in Parkinson's disease with and without dementia. Ann Neurol. 1995 Feb;37(2):242–245. doi: 10.1002/ana.410370215. [DOI] [PubMed] [Google Scholar]
  15. Kuusisto J., Koivisto K., Kervinen K., Mykkänen L., Helkala E. L., Vanhanen M., Hänninen T., Pyörälä K., Kesäniemi Y. A., Riekkinen P. Association of apolipoprotein E phenotypes with late onset Alzheimer's disease: population based study. BMJ. 1994 Sep 10;309(6955):636–638. doi: 10.1136/bmj.309.6955.636. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Letenneur L., Commenges D., Dartigues J. F., Barberger-Gateau P. Incidence of dementia and Alzheimer's disease in elderly community residents of south-western France. Int J Epidemiol. 1994 Dec;23(6):1256–1261. doi: 10.1093/ije/23.6.1256. [DOI] [PubMed] [Google Scholar]
  17. Li G., Silverman J. M., Altstiel L. D., Haroutunian V., Perl D. P., Purohit D., Birstein S., Lantz M., Mohs R. C., Davis K. L. Apolipoprotein E-epsilon 4 allele and familial risk in Alzheimer's disease. Genet Epidemiol. 1996;13(3):285–298. doi: 10.1002/(SICI)1098-2272(1996)13:3<285::AID-GEPI5>3.0.CO;2-5. [DOI] [PubMed] [Google Scholar]
  18. Mayeux R., Stern Y., Ottman R., Tatemichi T. K., Tang M. X., Maestre G., Ngai C., Tycko B., Ginsberg H. The apolipoprotein epsilon 4 allele in patients with Alzheimer's disease. Ann Neurol. 1993 Nov;34(5):752–754. doi: 10.1002/ana.410340527. [DOI] [PubMed] [Google Scholar]
  19. Nakagawa Y., Kitamoto T., Furukawa H., Ogomori K., Tateishi J. Allelic variation of apolipoprotein E in Japanese sporadic Creutzfeldt-Jakob disease patients. Neurosci Lett. 1995 Mar 10;187(3):209–211. doi: 10.1016/0304-3940(95)11366-5. [DOI] [PubMed] [Google Scholar]
  20. Payami H., Grimslid H., Oken B., Camicioli R., Sexton G., Dame A., Howieson D., Kaye J. A prospective study of cognitive health in the elderly (Oregon Brain Aging Study): effects of family history and apolipoprotein E genotype. Am J Hum Genet. 1997 Apr;60(4):948–956. [PMC free article] [PubMed] [Google Scholar]
  21. Poirier J., Davignon J., Bouthillier D., Kogan S., Bertrand P., Gauthier S. Apolipoprotein E polymorphism and Alzheimer's disease. Lancet. 1993 Sep 18;342(8873):697–699. doi: 10.1016/0140-6736(93)91705-q. [DOI] [PubMed] [Google Scholar]
  22. Ritchie K., Kildea D. Is senile dementia "age-related" or "ageing-related"?--evidence from meta-analysis of dementia prevalence in the oldest old. Lancet. 1995 Oct 7;346(8980):931–934. doi: 10.1016/s0140-6736(95)91556-7. [DOI] [PubMed] [Google Scholar]
  23. Saunders A. M., Strittmatter W. J., Schmechel D., George-Hyslop P. H., Pericak-Vance M. A., Joo S. H., Rosi B. L., Gusella J. F., Crapper-MacLachlan D. R., Alberts M. J. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology. 1993 Aug;43(8):1467–1472. doi: 10.1212/wnl.43.8.1467. [DOI] [PubMed] [Google Scholar]
  24. Slooter A. J., Tang M. X., van Duijn C. M., Stern Y., Ott A., Bell K., Breteler M. M., Van Broeckhoven C., Tatemichi T. K., Tycko B. Apolipoprotein E epsilon4 and the risk of dementia with stroke. A population-based investigation. JAMA. 1997 Mar 12;277(10):818–821. doi: 10.1001/jama.277.10.818. [DOI] [PubMed] [Google Scholar]
  25. Stern Y., Tang M. X., Denaro J., Mayeux R. Increased risk of mortality in Alzheimer's disease patients with more advanced educational and occupational attainment. Ann Neurol. 1995 May;37(5):590–595. doi: 10.1002/ana.410370508. [DOI] [PubMed] [Google Scholar]
  26. Strittmatter W. J., Saunders A. M., Schmechel D., Pericak-Vance M., Enghild J., Salvesen G. S., Roses A. D. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci U S A. 1993 Mar 1;90(5):1977–1981. doi: 10.1073/pnas.90.5.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Zubenko G. S., Stiffler S., Stabler S., Kopp U., Hughes H. B., Cohen B. M., Moossy J. Association of the apolipoprotein E epsilon 4 allele with clinical subtypes of autopsy-confirmed Alzheimer's disease. Am J Med Genet. 1994 Sep 15;54(3):199–205. doi: 10.1002/ajmg.1320540306. [DOI] [PubMed] [Google Scholar]
  28. van Duijn C. M., Clayton D., Chandra V., Fratiglioni L., Graves A. B., Heyman A., Jorm A. F., Kokmen E., Kondo K., Mortimer J. A. Familial aggregation of Alzheimer's disease and related disorders: a collaborative re-analysis of case-control studies. Int J Epidemiol. 1991;20 (Suppl 2):S13–S20. doi: 10.1093/ije/20.supplement_2.s13. [DOI] [PubMed] [Google Scholar]
  29. van Duijn C. M. Epidemiology of the dementias: recent developments and new approaches. J Neurol Neurosurg Psychiatry. 1996 May;60(5):478–488. doi: 10.1136/jnnp.60.5.478. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. van Duijn C. M., de Knijff P., Cruts M., Wehnert A., Havekes L. M., Hofman A., Van Broeckhoven C. Apolipoprotein E4 allele in a population-based study of early-onset Alzheimer's disease. Nat Genet. 1994 May;7(1):74–78. doi: 10.1038/ng0594-74. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Epidemiology and Community Health are provided here courtesy of BMJ Publishing Group

RESOURCES